• Guideline Summary
  • NGC:010426
  • 2006 Mar (revised 2014 May)

Guidelines on the diagnosis and management of Waldenström macroglobulinaemia.

  • Guideline Summary
  • NGC:010738
  • 2014 Oct

Management of malignant pleural effusion.

  • Guideline Summary
  • NGC:010940
  • 2015 Dec

The role of emerging therapy in the management of patients with diffuse low grade glioma.

  • Guideline Summary
  • NGC:010367
  • 2014

The role of postoperative radiation therapy for endometrial cancer: an ASTRO evidence-based guideline.

  • Guideline Summary
  • NGC:010384
  • 2013 Apr

Extragonadal germ cell tumours.

  • Guideline Summary
  • NGC:009685
  • 2009 Jan (revised 2012 Dec 13)

Stem cell transplantation in lymphoma.

  • Guideline Summary
  • NGC:010373
  • 2013 Sep

Optimal use of taxanes in metastatic breast cancer (MBC).

  • Guideline Summary
  • NGC:010375
  • 2013 Mar

The use of dexamethasone in patients with high grade gliomas.

  • Guideline Summary
  • NGC:010165
  • 1996 (revised 2013)

ACR Appropriateness Criteria® post-treatment follow-up of renal cell carcinoma.

  • Guideline Summary
  • NGC:010054
  • 2007 Jan 1 (revised 2013 Nov 1)

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

  • Guideline Summary
  • NGC:010264
  • 2012 Mar (revised 2013 Feb)

Preoperative and pretreatment investigations for malignant melanoma.

  • Guideline Summary
  • NGC:010540
  • 2013 Aug

EGFR-TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer.

  • Guideline Summary
  • NGC:010283
  • 2005 Sep (revised 2013 Dec)

Management of abnormal cervical cancer screening test results and cervical cancer precursors.

  • Guideline Summary
  • NGC:009492
  • 2012 Nov 28

Best evidence statement (BESt). Psycho-social interventions for primary caregivers of newly diagnosed pediatric oncology patients.

  • Guideline Summary
  • NGC:009073
  • 2003 Oct (revised 2012 Apr)

Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia (part review of technology appraisal guidance 70).

  • Guideline Summary
  • NGC:010022
  • 1998 Oct (revised 2013 Sep)

Treatment of primary breast cancer. A national clinical guideline.